Birgit C Schultes Intellia Therapeutics, Inc. (NTLA) insider trading activity

NTLA Quotes by TradingView

Birgit C Schultes is EVP, Chief Scientific Officer of Intellia Therapeutics, Inc.. Currently has a direct ownership of 105,184 shares of NTLA, which is worth approximately $915,100. The most recent transaction as insider was on Oct 01, 2025, when has been sold 31 shares (Common Stock) at a price of $17.38 per share, resulting in proceeds of $538. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 105K
0.03% 3M change
n/a 12M change
Total Value Held $915,100

Birgit C Schultes Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 01 2025
SELL
Open market or private sale
$538 $17.38 p/Share
31 Reduced 0.03%
105,184 Common Stock
Mar 01 2025
BUY
Grant, award, or other acquisition
-
37,600 Added 26.33%
105,215 Common Stock
BCS

Birgit C Schultes

EVP, Chief Scientific Officer
Cambridge, MA

Track Institutional and Insider Activities on NTLA

Follow Intellia Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NTLA shares.

Notify only if

Insider Trading

Get notified when an Intellia Therapeutics, Inc. insider buys or sells NTLA shares.

Notify only if

News

Receive news related to Intellia Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on NTLA